|
||
| Back to News Release Index |
|
For Release: 10 a.m. CST, Tuesday, Nov. 3,1998 Steve Roy UPDATE 98-222 |
Glenn to Experiment with New Technologies for Blood Replacements, Treatments for Cancer and Diabetes |
|
During the fifth day of Discovery's STS-95 mission, John Glenn is set to perform experiments today in the near-weightlessness of space that may lead to new technologies to fight colon cancer and control diabetes. Also, Glenn's studies may result in a genetically engineered blood replacement for transfusions. Glenn is scheduled to work with the Advanced Separation Commercial Payload today starting at 11:50 a.m. CST. This facility accurately separates different cells and cell components from one another and is a valuable tool for development of new technologies for innovative medical treatments. Principal investigator for the Advanced Separation Commercial Payload is Dr. Charles Lundquist, director of the Consortium for Materials Development in Space at the University of Alabama in Huntsville. Lundquist is available for interviews during the mission. Microgravity research uses the unique, near-weightless environment of space to unlock nature's secrets as part of the development of better disease-fighting drugs and improvement of manufacturing processes. The results can be of great benefit for the quality of our lives on Earth. During the STS-95 mission, the crew is conducting 54 experiments managed by NASA's Microgravity Research Program at the Marshall Space Flight Center in Huntsville Ala. The principal investigators for each of the 54 experiments are available for telephone interviews and in-person at either NASA's Johnson Space Center in Houston, Texas, NASA's Kennedy Space Center in Florida and at NASA's Marshall Center. What's Ahead: The next scheduled update on John Glenn's microgravity experiment activities will be issued at approximately 10 a.m. CST, Wednesday, Nov. 4. In the next 24 hours, Glenn, Commander Curtis L. Brown and Pilot Steven W. Lindsey are scheduled to be interviewed on NASA TV at 12:30 p.m. CST, Nov. 4. NASA TV may be viewed via cable in many areas, or directly from the satellite (GE-2, Transponder 9C, located at 85 degrees West longitude, vertical polarization, with a frequency of 3880 MHz, and audio at 6.8 Mhz.) For More Information: Please contact the Marshall Center Media Relations Office at (256) 544-0034. For daily news tips and background information about NASA's Microgravity Research Program experiments on the STS-95 mission, visit our Website: /centers/msfc/NEWSROOM/ |
|
|
|